Stanford University

University / College


Location: Stanford, CA, United States (USA) (US) US

ISNI: 0000000419368956

ROR: https://ror.org/00f54p054

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samples (2025) Saarela D, Lis P, Gomes S, Nirujogi RS, Dong W, Rawat E, Glendinning S, et al. Journal article Nodular fasciitis: a case series unveiling novel and rare gene fusions, including two cases with aggressive clinical behavior (2025) Saoud C, Agaimy A, Stöhr R, Michal M, Wang SKW, Mandavilli S, Charville GW, Linos K Journal article Genome-Wide Association Analyses of HPV16 and HPV18 Seropositivity Identify Susceptibility Loci for Cervical Cancer (2025) Beckhaus T, Kachuri L, Nakase T, Schürmann P, Eisenblätter R, Geerts M, Böhmer G, et al. Journal article Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing (2025) Tetzlaff SK, Reyhan E, Layer N, Bengtson CP, Heuer A, Schroers J, Faymonville AJ, et al. Journal article Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients (2025) Schmauch B, Cabeli V, Domingues OD, Le Douget JE, Hardy A, Belbahri R, Maussion C, et al. Journal article Quantification of Metal Artifacts in Metal Artifact Avoidance (2025) Münster N, Rohleder M, Kreher B, Maier A, Wang A Conference contribution Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein (2025) George BM, Eleftheriou M, Yankova E, Perr J, Chai P, Nestola GL, Almahayni K, et al. Journal article The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma: LYMPHOMA (2025) Kuehn JC, Neidert NN, Zhang J, Mutter J, Alig S, Klingler C, Hummel F, et al. Journal article Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials (2025) Badve SV, Bilal A, Lee MM, Sattar N, Gerstein HC, Ruff CT, McMurray JJ, et al. Journal article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article